MarketPeel
Insider Trading Intelligence
AL

Ann Lee

COYA
DIRECTOR · COYA THERAPEUTICS, INC. · CIK 0001953080
FILING MIX · LIFETIME89%/11%
BUYS
8
SELLS
1
TOTAL VALUE
$29.5K
COMPANIES
1
ACTIVE SINCE
Jan 2023
HOLDINGS NOW
10,000
AVG SELL PX
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Ann Lee, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+3.13%+2.51%+0.62%+0.62%
14d1+100.00%+17.09%+2.53%+14.56%+14.56%
30d1+100.00%+15.67%-1.20%+16.86%+16.86%
60d1+100.00%+41.31%-3.53%+44.84%+44.84%
90d1+100.00%+55.27%+4.04%+51.23%+51.23%
180d1+100.00%+114.25%+14.87%+99.38%+99.38%
1y1+100.00%+69.52%+29.74%+39.77%+39.77%
2y1+100.00%+87.75%+48.48%+39.27%+39.27%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COYA · 10,000 shares · as of Jan 2, 2026
04,3708,74013,10917,479202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 8 buys / 1 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 2, 2026Jan 6, 2026View →
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,0005,000Feb 25, 2025Feb 25, 2025View →
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jan 1, 2025Jan 3, 2025View →
COYA
COYA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jan 1, 2024Jan 19, 2024View →
COYA
COYA THERAPEUTICS, INC.
PURCHASE
1,000$3.62$3.6K17,479Aug 22, 2023Mar 5, 2024View →
COYA
COYA THERAPEUTICS, INC.
SALE
6,479Jan 3, 2023Jan 4, 2023View →
COYA
COYA THERAPEUTICS, INC.
PURCHASE
6,479$4.00$25.9K16,479Jan 3, 2023Jan 4, 2023View →
COYA
COYA THERAPEUTICS, INC.
PURCHASE
5,0009,479Jan 3, 2023Jan 4, 2023View →
COYA
COYA THERAPEUTICS, INC.
PURCHASE
10,00010,000Jan 3, 2023Jan 4, 2023View →
Other insiders · COYA
Loading peer insiders…
About this filer
CIK 0001953080
ROLE
Director
PRIMARY
COYA
COMPANIES
1
ACTIVE SINCE
Jan 2023
MARKETPEEL · /INSIDER/0001953080DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback